FDA
approval
· 2021-10-27
FDA Approved: VALSARTAN — Original Application (ScieGen Pharmaceuticals, INC.)
Summary
FDA approves the original application for VALSARTAN (Valsartan) from ScieGen Pharmaceuticals as a generic angiotensin II receptor blocker. It covers indications…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VALSARTAN (VALSARTAN)